Association Between Surgical Start Time and Major Morbidity or Mortality After Pulmonary Resection.

Background: The objective of this study was to examine the association between the operative start time of pulmonary resections and the incidence of major morbidity or mortality after resection.

Methods: The Society of Thoracic Surgeons General Thoracic Surgery Database was queried for patients who underwent lobar or sublobar pulmonary resections for non-small cell lung cancer between 2015 and 2023. Exclusion criteria included missing data on 30-day mortality, sex, and tumor staging, emergent cases, multiple primary procedures, and an American Society of Anesthesiologists score ≥IV or Eastern Cooperative Oncology Group score of ≥4.

Association Between Social Vulnerability Index and Time to Treatment in Resectable Non-Small Cell Lung Cancer.

Background: Social determinants of health, including race, education, and insurance status, have been linked to delays in non-small cell lung cancer (NSCLC) treatment, although quantification has been challenging. This study investigated whether the social vulnerability index (SVI), a quantitative measure of social determinants of health, is associated with time to treatment.

Methods: Patients with surgically resected NSCLC at a single institution from 2010 to 2021 were identified.

Difficult Decisions in the Multidisciplinary Treatment of Resectable Non-small Cell Lung Cancer.

The management of resectable non-small cell lung cancer (NSCLC) has evolved dramatically over the past three decades. Once limited to surgery, treatment strategies now include chemotherapy, immunotherapy, radiation, and targeted therapies. Despite advances in clinical trials and updated guidelines, several gray areas persist in practice.